293 related articles for article (PubMed ID: 28647381)
1. Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
Ujino M; Sugimoto N; Koizumi Y; Ro S; Kojima Y; Asae KH; Yamashita N; Ohta K; Nagase H
Allergol Int; 2017 Sep; 66S():S21-S26. PubMed ID: 28647381
[TBL] [Abstract][Full Text] [Related]
2. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
[TBL] [Abstract][Full Text] [Related]
3. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
4. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
[TBL] [Abstract][Full Text] [Related]
5. Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
Fukunaga J; Abe M; Murai A; Akitake Y; Hosokawa M; Takahashi M
Int Immunopharmacol; 2007 Dec; 7(14):1852-61. PubMed ID: 18039522
[TBL] [Abstract][Full Text] [Related]
6. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
7. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.
Henderson WR; Tang LO; Chu SJ; Tsao SM; Chiang GK; Jones F; Jonas M; Pae C; Wang H; Chi EY
Am J Respir Crit Care Med; 2002 Jan; 165(1):108-16. PubMed ID: 11779739
[TBL] [Abstract][Full Text] [Related]
8. Effect of selective cysteinyl leukotriene receptor antagonists on airway inflammation and matrix metalloproteinase expression in a mouse asthma model.
Hsu CH; Hu CM; Lu KH; Yang SF; Tsai CH; Ko CL; Sun HL; Lue KH
Pediatr Neonatol; 2012 Aug; 53(4):235-44. PubMed ID: 22964281
[TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotriene upregulates IL-11 expression in allergic airway disease of mice.
Lee KS; Kim SR; Park HS; Park SJ; Min KH; Lee KY; Jin SM; Lee YC
J Allergy Clin Immunol; 2007 Jan; 119(1):141-9. PubMed ID: 17208595
[TBL] [Abstract][Full Text] [Related]
10. Montelukast reduces inhaled chlorine triggered airway hyperresponsiveness and airway inflammation in the mouse.
Hamamoto Y; Ano S; Allard B; O'Sullivan M; McGovern TK; Martin JG
Br J Pharmacol; 2017 Oct; 174(19):3346-3358. PubMed ID: 28718891
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of galectin-9 on double-stranded RNA-induced airway hyperresponsiveness in an exacerbation model of mite antigen-induced asthma in mice.
Katoh S; Shimizu H; Obase Y; Oomizu S; Niki T; Ikeda M; Mouri K; Kobashi Y; Hirashima M; Oka M
Exp Lung Res; 2013 Dec; 39(10):453-62. PubMed ID: 24246013
[TBL] [Abstract][Full Text] [Related]
12. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
[TBL] [Abstract][Full Text] [Related]
13. Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.
Han J; Jia Y; Takeda K; Shiraishi Y; Okamoto M; Dakhama A; Gelfand EW
Am J Respir Crit Care Med; 2010 Aug; 182(4):455-63. PubMed ID: 20442434
[TBL] [Abstract][Full Text] [Related]
14. Five-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates poly (I:C)-induced airway inflammation in a murine model of asthma.
Kim TB; Kim SY; Moon KA; Park CS; Jang MK; Yun ES; Cho YS; Moon HB; Lee KY
Clin Exp Allergy; 2007 Nov; 37(11):1709-19. PubMed ID: 17877757
[TBL] [Abstract][Full Text] [Related]
15. Effects of montelukast on subepithelial/peribronchial fibrosis in a murine model of ovalbumin induced chronic asthma.
Shin IS; Jeon WY; Shin HK; Lee MY
Int Immunopharmacol; 2013 Nov; 17(3):867-73. PubMed ID: 24126112
[TBL] [Abstract][Full Text] [Related]
16. TNFα-blockade stabilizes local airway hyperresponsiveness during TLR-induced exacerbations in murine model of asthma.
Starkhammar M; Kumlien Georén S; Dahlén SE; Cardell LO; Adner M
Respir Res; 2015 Oct; 16():129. PubMed ID: 26494305
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma.
Wu AY; Chik SC; Chan AW; Li Z; Tsang KW; Li W
Clin Exp Allergy; 2003 Mar; 33(3):359-66. PubMed ID: 12614451
[TBL] [Abstract][Full Text] [Related]
18. Siraitia grosvenorii residual extract attenuates ovalbumin-induced lung inflammation by down-regulating IL-4, IL-5, IL-13, IL-17, and MUC5AC expression in mice.
Sung YY; Kim SH; Yuk HJ; Yang WK; Lee YM; Son E; Kim DS
Phytomedicine; 2019 Aug; 61():152835. PubMed ID: 31035047
[TBL] [Abstract][Full Text] [Related]
19. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Wong WS; Zhu H; Liao W
Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
Nadeem A; Obiefuna PC; Wilson CN; Mustafa SJ
Eur J Pharmacol; 2006 Dec; 551(1-3):116-24. PubMed ID: 17027749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
